Trial Profile
Study of effects of enzalutamide and abiraterone on metastatic castration-resistant prostate cancer patients physical, social and emotional function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2018
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology